RARE vs RMR · rev $350.0M vs P/E 15, rev $700.3M
Ultragenyx (RARE) versus RMR Group Inc (RMR) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
RMR Group Inc (RMR) is a real estate services company listed on US.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported RMR revenue for 2025-09-30 was $700.3M. Net income was $38.7M. RMR currently screens at market cap $295.9M and trailing P/E 14.6.
RARE currently screens at market cap $2.79B. RMR currently screens at market cap $295.9M and trailing P/E 14.6.
Not investment advice. Open the RARE and RMR stock pages for the full models.
Not investment advice.